Table 5.
Percentages receiving follow-up treatment† among respondents using services in the WMH surveys
| Test of Difference in Probability of Follow-up Treatment By Severity | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Country income level | Country | Any Severity | Severe | Moderate | Mild | None | χ2 | (p-value) | ||||||||||
| N |
%‡ |
se |
N |
%§ |
se |
N |
%§ |
se |
N |
%§ |
se |
N |
%§ |
se |
(1 or 3 df)¶ |
|||
| Low | ||||||||||||||||||
| Nigeria | 47 | 76.3 | 8.7 | 6 | -∥ | -∥ | 6 | -∥ | -∥ | 13 | 74.6 | 9.2 | 22 | 74.6 | 9.2 | 0.4 | (.512) | |
| Low-Middle | ||||||||||||||||||
| China | 56 | 77.6 | 6.0 | 4 | -∥ | -∥ | 6 | -∥ | -∥ | 3 | 80.8 | 6.8 | 43 | 80.8 | 6.8 | 1.0 | (.328) | |
| Colombia | 158 | 72.0 | 4.3 | 49 | 92.6 | 3.5 | 31 | 73.1 | 7.9 | 20 | 61.7 | 11.3 | 58 | 63.6 | 7.9 | 12.3* | (.006) | |
| South Africa | 601 | 89.1 | 1.7 | 42 | 93.9 | 3.9 | 63 | 95.7 | 3.0 | 58 | 87.4 | 3.7 | 438 | 88.0 | 2.2 | 3.0 | (.394) | |
| Ukraine | 167 | 79.1 | 3.8 | 44 | 92.3 | 3.6 | 51 | 82.3 | 4.5 | 14 | -∥ | -∥ | 58 | 71.8 | 7.0 | 12.5* | (.006) | |
| High-Middle | ||||||||||||||||||
| Lebanon | 62 | 78.9 | 6.9 | 17 | 84.1 | 4.4 | 15 | 84.1 | 4.4 | 7 | 75.7 | 10.2 | 23 | 75.7 | 10.2 | 0.8 | (.367) | |
| Mexico | 180 | 74.5 | 4.4 | 40 | 85.5 | 4.2 | 41 | 76.6 | 6.7 | 25 | 84.3 | 6.9 | 74 | 67.8 | 7.7 | 6.0 | (.110) | |
| High | ||||||||||||||||||
| Belgium | 165 | 84.3 | 3.9 | 42 | 84.4 | 9.5 | 27 | 84.3 | 10.4 | 12 | -∥ | -∥ | 84 | 83.1 | 5.1 | 3.1 | (.376) | |
| France | 235 | 86.0 | 3.9 | 49 | 87.5 | 4.7 | 65 | 97.3 | 1.6 | 35 | 89.7 | 4.4 | 86 | 80.0 | 6.9 | 7.8 | (.051) | |
| Germany | 152 | 70.2 | 5.1 | 28 | 89.2 | 8.5 | 37 | 97.1 | 0.7 | 23 | -∥ | -∥ | 64 | 61.1 | 7.4 | 66.4* | (<.001) | |
| Israel | 364 | 86.1 | 1.8 | 73 | 90.7 | 3.2 | 48 | 89.2 | 4.2 | 17 | -∥ | -∥ | 226 | 83.6 | 2.4 | 3.3 | (.344) | |
| Italy | 129 | 94.5 | 1.5 | 28 | -∥ | -∥ | 34 | 93.1 | 3.7 | 19 | -∥ | -∥ | 48 | 94.4 | 2.4 | 1.3 | (.728) | |
| Japan | 83 | 89.8 | 2.6 | 9 | -∥ | -∥ | 13 | -∥ | -∥ | 9 | 91.2 | 3.3 | 52 | 91.2 | 3.3 | 0.9 | (.332) | |
| Netherlands | 183 | 85.9 | 4.3 | 53 | 96.4 | 2.1 | 35 | 98.9 | 1.2 | 15 | -∥ | -∥ | 80 | 78.5 | 7.2 | 10.0* | (.007) | |
| New Zealand | 1394 | 85.7 | 1.3 | 421 | 92.5 | 1.4 | 368 | 88.7 | 1.8 | 151 | 83.5 | 3.2 | 454 | 81.0 | 2.8 | 15.1* | (.002) | |
| Spain | 341 | 88.8 | 2.6 | 73 | 95.3 | 1.9 | 86 | 92.6 | 3.0 | 33 | 90.8 | 6.2 | 149 | 84.7 | 4.7 | 5.8 | (.121) | |
| USA | 1313 | 86.8 | 1.4 | 362 | 93.2 | 1.7 | 354 | 88.4 | 2.0 | 187 | 83.0 | 2.9 | 410 | 83.3 | 2.6 | 17.2* | (.001) | |
| χ 2 16 # | 67.1 (<.001) | 25.4 (.062) | 71.5 (<.001) | 21.3 (.129) | 47.9 (<.001) | |||||||||||||
Significant at the .05 level, two-sided test.
Follow-up treatment was defined as receiving 2 or more visits to any service sector, or being in ongoing treatment at interview.
Percents based on entire part II samples.
Percents are those receiving follow-up treatment among those in treatment within each level of severity.
Percents not reported if the number of cases with any treatment in a level of severity < 30.
One degree of freedom Chi-Square tests were performed for Nigeria, Lebanon, Japan and China, where combined Severe and Moderate was compared against combined Mild and None category. Three degree of freedom tests were performed for all other countries.
χ213 is from a model predicting follow-up treatment among respondents in each level of severity that used any 12-month services.